Andy Kim - Samsung Biologics Exec center
| 207940 Stock | 771,000 4,000 0.52% |
Executive
Andy Kim is Exec center of Samsung Biologics Co
| Age | 59 |
| Phone | (82) 33 455 3825 |
| Web | www.samsungbiologics.com |
Samsung Biologics Management Efficiency
The company has return on total asset (ROA) of 0.0422 % which means that it generated a profit of $0.0422 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0751 %, meaning that it generated $0.0751 on every $100 dollars invested by stockholders. Samsung Biologics' management efficiency ratios could be used to measure how well Samsung Biologics manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 3 records | EXECUTIVE Age | ||
| HyungRae Cho | Sk BiopharmaceuticalsCo | N/A | |
| Seong Lee | ISU Abxis Co | 53 | |
| Jin Shin | ISU Abxis Co | N/A | |
Management Performance
| Return On Equity | 0.0751 | |||
| Return On Asset | 0.0422 |
Samsung Biologics Leadership Team
Elected by the shareholders, the Samsung Biologics' board of directors comprises two types of representatives: Samsung Biologics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Samsung. The board's role is to monitor Samsung Biologics' management team and ensure that shareholders' interests are well served. Samsung Biologics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Samsung Biologics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Hoyeol Yoon, Ex VP | ||
| John Rim, Pres CEO | ||
| James Park, MD VP | ||
| Doyoung Heo, VP Relations | ||
| James Choi, Chief VP | ||
| Hyung Moon, Head VP | ||
| Andy Kim, Exec center | ||
| DongJoong Kim, Ex CFO | ||
| Yong Park, CHRO VP | ||
| TaeHan Kim, Ex Chairman |
Samsung Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Samsung Biologics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0751 | |||
| Return On Asset | 0.0422 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.32 % | |||
| Current Valuation | 58.92 T | |||
| Shares Outstanding | 71.17 M | |||
| Shares Owned By Insiders | 75.18 % | |||
| Shares Owned By Institutions | 13.80 % | |||
| Price To Book | 6.92 X | |||
| Price To Sales | 23.45 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Samsung Biologics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Samsung Biologics' short interest history, or implied volatility extrapolated from Samsung Biologics options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Samsung Biologics Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Samsung Biologics information on this page should be used as a complementary analysis to other Samsung Biologics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Samsung Stock analysis
When running Samsung Biologics' price analysis, check to measure Samsung Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Samsung Biologics is operating at the current time. Most of Samsung Biologics' value examination focuses on studying past and present price action to predict the probability of Samsung Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Samsung Biologics' price. Additionally, you may evaluate how the addition of Samsung Biologics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |